Related Experiment Video
Updated: Jun 18, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
Percutaneous Neuromodulation for Atrial Fibrillation.
Mohamed Zuhair1, Daniel Keene1, Prapa Kanagaratnam1
1National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12, UK.
Cardiac Electrophysiology Clinics
|July 31, 2024
Summary
Neuromodulation techniques like vagus nerve stimulation and ganglionated plexi ablation show promise for treating atrial fibrillation (AF). Further clinical trials are needed to confirm their safety and effectiveness in managing AF.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- Autonomic nervous system dysfunction plays a role in AF pathogenesis.
- Current AF treatments have limitations.
Purpose of the Study:
- To explore percutaneous neuromodulation techniques for AF treatment.
- To evaluate the potential of ganglionated plexi (GP) ablation and vagus nerve stimulation in managing AF.
- To discuss noninvasive neuromodulation methods for AF.
Main Methods:
- Review of percutaneous neuromodulation techniques for AF.
- Exploration of ganglionated plexi (GP) ablation and vagus nerve stimulation.
- Discussion of transcutaneous low-level tragus stimulation.
Main Results:
- Neuromodulation offers potential for AF treatment by targeting autonomic triggers.
- Early trials of transcutaneous low-level tragus stimulation show reduced AF burden.
- GP ablation may modulate AF triggers and maintenance.
Conclusions:
- Percutaneous neuromodulation is a promising therapeutic avenue for AF.
- Further rigorous clinical trials are essential to validate safety, reproducibility, and efficacy.
- Neuromodulation techniques require more research for widespread AF treatment adoption.
